RAMM Pharma Corp. Provides Update on Litigation
21. Mai 2024 17:01 ET
|
RAMM Pharma Corp.
Not for Dissemination in the US or through US Newswire Services TORONTO, May 21, 2024 (GLOBE NEWSWIRE) -- RAMM Pharma Corp. (including its wholly owned subsidiaries, the “Company” or "RAMM") (CSE:...
RAMM Pharma Corp. Announces Corporate Update
28. März 2024 15:49 ET
|
RAMM Pharma Corp.
TORONTO, March 28, 2024 (GLOBE NEWSWIRE) -- RAMM Pharma Corp. (including its wholly owned subsidiaries, the “Company” or "RAMM") (CSE: RAMM), is pleased to advise its shareholders that in accordance...
RAMM Pharma Corp. Announces Corporate Update
19. März 2024 09:29 ET
|
RAMM Pharma Corp.
TORONTO, March 19, 2024 (GLOBE NEWSWIRE) -- On September 5th 2023, RAMM Pharma Corp. (including its wholly owned subsidiaries, the “Company” or "RAMM") (CSE: RAMM), announced its intention to...
RAMM Pharma Corp. Announces Corporate Update
14. Dezember 2023 16:44 ET
|
RAMM Pharma Corp.
TORONTO, Dec. 14, 2023 (GLOBE NEWSWIRE) -- On September 5th 2023, RAMM Pharma Corp. (including its wholly owned subsidiaries, the “Company” or "RAMM") (CSE: RAMM), announced its intention to...
RAMM Pharma Corp. Announces Corporate Update
30. November 2023 17:00 ET
|
RAMM Pharma Corp.
TORONTO, Nov. 30, 2023 (GLOBE NEWSWIRE) -- RAMM Pharma Corp. (including its wholly owned subsidiaries, the “Company” or "RAMM") (CSE: RAMM), announces that it has rescinded a grant of 2,000,000...
RAMM Pharma Corp. Announces Corporate Update.
17. November 2023 18:56 ET
|
RAMM Pharma Corp.
TORONTO, Nov. 17, 2023 (GLOBE NEWSWIRE) -- On September 5th 2023, RAMM Pharma Corp. (including its wholly owned subsidiaries, the “Company” or "RAMM") (CSE: RAMM), announced its intention to...
RAMM Pharma Corp. Announces Corporate Update
11. Oktober 2023 11:49 ET
|
RAMM Pharma Corp.
TORONTO, Oct. 11, 2023 (GLOBE NEWSWIRE) -- On September 5th, 2023, RAMM Pharma Corp. (including its wholly owned subsidiaries, the “Company” or "RAMM") (CSE: RAMM), announced its intention to...
RAMM Pharma Corp. Announces Clarification of its Corporate Update of September 12th
27. September 2023 19:10 ET
|
RAMM Pharma Corp.
TORONTO, Sept. 27, 2023 (GLOBE NEWSWIRE) -- On September 5th 2023, RAMM Pharma Corp. (including its wholly owned subsidiaries, the “Company” or "RAMM") (CSE: RAMM), announced its intention to...
RAMM Pharma Corp. Announces Corporate Update
12. September 2023 09:59 ET
|
RAMM Pharma Corp.
TORONTO, Sept. 12, 2023 (GLOBE NEWSWIRE) -- On September 5th 2023, RAMM Pharma Corp. (including its wholly owned subsidiaries, the “Company” or "RAMM") (CSE: RAMM), announced its intention to...
RAMM Pharma Corp. Announces Non-Brokered Private Placement and Intention to Commence Normal Course Issuer Bid
05. September 2023 17:37 ET
|
RAMM Pharma Corp.
TORONTO, Sept. 05, 2023 (GLOBE NEWSWIRE) -- RAMM Pharma Corp. (including its wholly owned subsidiaries, the “Company” or "RAMM") (CSE: RAMM), announces that it intends to complete a non-brokered...